EXPOSED: Whistleblower Reveals How Pharma Giant Engineered 'Crossfire' Study That Silenced Generic Drug Competitors
Off the record, sources inside the regulatory review committee confirm that the explosive study, leaked late last night, was deliberately crafted as a 'crossfire' to discredit smaller rivals. Test results were cherry-picked, data manipulated, and patient safety twisted into a tool for market domination. The dossier—stamped 'eyes only'—shows a direct line from executive bonuses to the study's damning conclusions. The public thinks they're witnessing a legitimate turf war; in truth, it's a premeditated firing squad. I’m told the lead researcher has already vanished, and the media blackout begins at dawn. Keep this close—when it breaks, the fallout will be radioactive. Do not cite me.